Search Results1-9 of  9

  • KANDORI Shuya ID: 9000006685699

    Articles in CiNii:20

    • Real-time Virtual Sonography for Prostate Biopsy : Initial Experience （2008）
    • AVP-011 Real-time virtual sonographyを用いた前立腺生検の初期成績(前立腺・その他,総会賞応募ビデオ,第96回日本泌尿器科学会総会) （2008）
    • APP-007 Real time balloon inflation Elastography(RBIE)による前立腺癌局在診断 : 57例によるイメージ像と摘出病理所見との比較(前立腺癌/診断・マーカー・統計,総会賞応募ポスター,第96回日本泌尿器科学会総会) （2008）
  • KANDORI Shuya ID: 9000018530461

    Department of Urology, Institute of Clinical Medicine, University of Tsukuba Graduate School of Comprehensive Human Sciences （2010 from CiNii）

    Articles in CiNii:1

    • A case of metastatic testicular cancer complicated by pulmonary hemorrhage due to choriocarcinoma syndrome （2010）
  • Kandori Shuya ID: 9000345442353

    Articles in CiNii:1

    • Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples （2016）
  • Kandori Shuya ID: 9000376923630

    Articles in CiNii:1

    • TRPV4-dependent induction of a novel mammalian cold-inducible protein SRSF5 as well as CIRP and RBM3 （2017）
  • Kandori Shuya ID: 9000397828300

    Articles in CiNii:1

    • Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin （2018）
  • Kandori Shuya ID: 9000403963703

    Articles in CiNii:1

    • The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients （2019）
  • Shuya KANDORI ID: 9000403954317

    Articles in CiNii:1

    • Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model （2019）
  • Shuya KANDORI ID: 9000403954659

    Articles in CiNii:1

    • Systemic transduction of p16INK4a antitumor peptide inhibits lung metastasis of the MBT‑2 bladder tumor cell line in mice （2019）
  • Shuya KANDORI ID: 9000406381779

    Articles in CiNii:1

    • TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer （2019）
Page Top